CAVION

Cavion is a clinical stage pharmaceutical company committed to providing patients with therapies for cancer and neurologic diseases through the development of drugs that selectively inhibit the T-type calcium channel (Cav3). Built on the discovery by Cavion’s founders that ion channels are a target for the treatment of solid tumor cancers, they were the first company to invent therapies engaging Cav3 for the treatment of solid tumors. The innovative idea of treating pathologically prolifera... ting, non-electrically excitable cells by targeting an ion channel has already shown success in preclinical studies and is being tested in Phase 1 safety and dose-finding clinical trials in brain cancer. Their technology is intended to magnify the effects of combined chemotherapy, radiation, and targeted therapies for all solid tumor cancers. Their neurology program uses superior chemistry and clinical expertise to deliver a novel class of drugs that will provide patients with treatments for neurologic diseases. While Cav3 is an established target in neurology, particularly neuropathic pain, Cavion is working to bring the first non-addictive, non-opioid T-type calcium channel antagonist to patients with neuropathic pain. Given that Cav3 plays a role in numerous pathologic conditions, Cavion is simultaneously developing therapies for additional neurologic afflictions such as essential tremor, Parkinson’s disease, epilepsy, and Angelman syndrome.

#SimilarOrganizations #People #Financial #Website #More

CAVION

Industry:

Biotechnology Health Care Pharmaceutical

Founded:

2003-01-01

Address:

Charlottesville, Virginia, United States

Country:

United States

Website Url:

http://www.cavionpharma.com

Total Employee:

11+

Status:

Active

Contact:

(434) 200-8442

Email Addresses:

[email protected]

Total Funding:

31.1 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF Google Analytics LetsEncrypt Google Tag Manager Google Universal Analytics Apache Global Site Tag Microsoft Exchange Online

Similar Organizations

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

Current Employees Featured

bruce-a-silver_image

Bruce A. Silver
Bruce A. Silver Chief Medical Officer @ Cavion
Chief Medical Officer

lloyd-gray_image

Lloyd Gray
Lloyd Gray Founder , Vice President @ Cavion
Founder , Vice President

timothy-macdonald_image

Timothy Macdonald
Timothy Macdonald Founder and Vice President of Drug Discovery @ Cavion
Founder and Vice President of Drug Discovery

Founder

andrew-j-krouse_image

Andrew J. Krouse

lloyd-gray_image

Lloyd Gray

timothy-macdonald_image

Timothy Macdonald

Investors List

ensoventures_image

Official Site Inspections

http://www.cavionpharma.com

Host Informations
Whois Informations

Loading ...